Oneview Healthcare PLC (ASX: ONE) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Oneview Healthcare PLC Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$213.76 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
804.69 million
Earnings per share
-0.016
Dividend per share
N/A
Year To Date Return
-5.08%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Oneview Healthcare PLC (ASX: ONE)
Latest News
Share Gainers
These small cap ASX shares are on the rise on Friday
❮2
ONE ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Oneview Healthcare PLC
Oneview Healthcare PLC provides patient engagement and clinical workflow technology solutions to healthcare facilities. It serves hospitals and healthcare systems, academic medical centers, and pediatric hospitals. Oneview Healthcare's Care Experience Platform (CXP) provides a unified set of digital tools in a single bedside solution and connects patients, families, and care teams with services, education, and information during hospital stays.
ONE Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 11 Jun 2025 | $0.28 | $0.02 | 7.69% | 337,250 | $0.26 | $0.28 | $0.26 |
| 10 Jun 2025 | $0.26 | $-0.01 | -3.77% | 479,554 | $0.26 | $0.26 | $0.23 |
| 06 Jun 2025 | $0.27 | $0.00 | 0.00% | 10,220 | $0.27 | $0.27 | $0.27 |
| 05 Jun 2025 | $0.27 | $-0.01 | -3.70% | 66,267 | $0.27 | $0.27 | $0.27 |
| 04 Jun 2025 | $0.27 | $0.01 | 3.77% | 66,532 | $0.27 | $0.27 | $0.27 |
| 03 Jun 2025 | $0.27 | $0.00 | 0.00% | 136,480 | $0.27 | $0.27 | $0.27 |
| 02 Jun 2025 | $0.27 | $0.00 | 0.00% | 52,716 | $0.27 | $0.27 | $0.27 |
| 30 May 2025 | $0.27 | $-0.01 | -3.64% | 550,849 | $0.27 | $0.27 | $0.26 |
| 29 May 2025 | $0.28 | $0.01 | 3.70% | 44,854 | $0.27 | $0.28 | $0.27 |
| 28 May 2025 | $0.27 | $0.00 | 0.00% | 131,089 | $0.27 | $0.27 | $0.27 |
| 27 May 2025 | $0.27 | $0.01 | 3.77% | 171,298 | $0.27 | $0.27 | $0.27 |
| 26 May 2025 | $0.27 | $0.01 | 3.85% | 1,922 | $0.27 | $0.27 | $0.27 |
| 23 May 2025 | $0.26 | $-0.01 | -3.77% | 218,321 | $0.26 | $0.26 | $0.26 |
| 22 May 2025 | $0.27 | $0.00 | 0.00% | 161,576 | $0.26 | $0.27 | $0.26 |
| 21 May 2025 | $0.26 | $0.00 | 0.00% | 89,240 | $0.27 | $0.27 | $0.26 |
| 20 May 2025 | $0.27 | $-0.01 | -3.64% | 588,020 | $0.27 | $0.27 | $0.26 |
| 19 May 2025 | $0.28 | $0.01 | 3.70% | 9,467 | $0.27 | $0.28 | $0.27 |
| 16 May 2025 | $0.27 | $0.00 | 0.00% | 151,456 | $0.27 | $0.27 | $0.27 |
| 15 May 2025 | $0.27 | $-0.02 | -7.02% | 134,432 | $0.27 | $0.27 | $0.27 |
| 14 May 2025 | $0.29 | $-0.01 | -3.45% | 17,393 | $0.29 | $0.29 | $0.29 |
| 13 May 2025 | $0.29 | $0.01 | 3.51% | 236,334 | $0.29 | $0.29 | $0.28 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 11 Mar 2025 | James Fitter | Exercise | 1,600,000 | $512,000 |
Conversion of securities. 13,000,000 Restricted Share Units
|
| 11 Mar 2025 | James Fitter | Buy | 1,600,000 | $512,000 |
Conversion of securities.
|
| 11 Mar 2025 | Joseph Rooney | Buy | 470,833 | $150,666 |
Conversion of securities.
|
| 11 Mar 2025 | Joseph Rooney | Exercise | 470,833 | $150,666 |
Conversion of securities. 234,375 Restricted Share Units
|
| 11 Mar 2025 | Joseph Rooney | Sell | 249,541 | $79,135 |
As advised by the company. Tax Sale
|
| 11 Mar 2025 | Nashina Asaria | Sell | 102,083 | $32,373 |
As advised by the company. Tax Sale
|
| 11 Mar 2025 | Nashina Asaria | Exercise | 208,333 | $66,666 |
Conversion of securities. 156,250 Restricted Share Units
|
| 11 Mar 2025 | Nashina Asaria | Buy | 208,333 | $66,666 |
Conversion of securities.
|
| 11 Mar 2025 | Barbara Nelson | Exercise | 208,333 | $66,666 |
Conversion of securities. 1,182,065 Restricted Share Units
|
| 11 Mar 2025 | Barbara Nelson | Buy | 208,333 | $66,666 |
Conversion of securities.
|
| 11 Mar 2025 | Barbara Nelson | Sell | 102,083 | $32,373 |
As advised by the company. Tax Sale Consideration
|
| 11 Mar 2025 | Darragh Lyons | Buy | 150,000 | $48,000 |
Conversion of securities.
|
| 11 Mar 2025 | Darragh Lyons | Exercise | 150,000 | $48,000 |
Conversion of securities. 3,750,000 Restricted Share Units
|
| 26 Feb 2025 | James Fitter | Expiry | 6,400,000 | $2,208,000 |
As advised by the company. 14,600,000 Restricted Share Units, EXPIRED
|
| 17 Dec 2024 | Barbara Nelson | Buy | 248,275 | $78,331 |
On-market trade.
|
| 13 Dec 2024 | Darragh Lyons | Buy | 464,540 | $148,653 |
On-market trade. 788,604 CDIs
|
| 06 Dec 2024 | Darragh Lyons | Buy | 324,064 | $100,844 |
On-market trade. CDIs
|
| 02 Dec 2024 | Joseph Rooney | Issued | 234,375 | $75,000 |
Issue of securities. 705,208 Restricted Share Units
|
| 02 Dec 2024 | Mark Cullen | Issued | 234,375 | $75,000 |
Issue of securities. 1,416,440 Restricted
Share Units |
| 02 Dec 2024 | Nashina Asaria | Issued | 156,250 | $50,000 |
Issue of securities. 364,583 Restricted Share Units
|
| 02 Dec 2024 | Barbara Nelson | Issued | 312,500 | $100,000 |
Issue of securities. 1,390,398 Restricted Share Units
|
| 31 Oct 2024 | Darragh Lyons | Issued | 3,900,000 | $1,287,000 |
Issue of securities. 3,900,000 Restricted Share Units
|
| 31 Oct 2024 | James Fitter | Issued | 9,000,000 | $2,970,000 |
Issue of securities. 21,000,000 Restricted
Share Units |
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr James Fitter | Chief Executive OfficerExecutive Director | Jan 2013 |
Mr Fitter has over 25 years of experience in global financial markets, including living and working on four continents, James brings international business acumen to the role. Prior to Oneview, he founded and managed an independent asset management company and spent over a decade as a professional investor, corporate governance advocate and independent advisor. This financial background provides him with a perspective on the healthcare technology sector
|
| Mr Joseph Rooney | Non-Executive Director | Feb 2016 |
Mr Rooney is also Chair of Fundraising for the Clongowes Wood College Foundation. Until the end of 2012, Joe was a partner and global strategist at Autonomy Capital Research LLP, a global macro hedge fund. Prior to this, he held several senior positions at Lehman Brothers Inc, where, as a Managing Director, he was the Head of Global Equity Strategy and a trustee of their UK pension fund. He is a member of the Risk Committee.
|
| Mr Mark Cullen | Non-Executive Director | Dec 2015 |
Mr Cullen has rejoined the Board after retiring from a 30-year career with Deutsche Bank and DWS Asset Management, most recently as CEO of DWS Americas & COO of DWS Group GmbH & Co. Mark currently acts as a Senior Advisor to BlackRock's technology division in London and New York. He is Chair of the Risk Committee.
|
| Ms Nashina Asaria | Non-Executive Director | May 2021 |
Ms Asaria is a Trustee and Director at Ashinaga Foundation UK. She is also on the Advisory Boards of several HealthTech and FinTech AI-related companies including Cylerity, Symbiosis and Simplici.io. Nashina has held roles, including Chief Product Officer at Nanthealth and Chief Product and Marketing Officer at Cloudbreak Health, where she led revenue growth. Her expertise spans product strategy, commercialization and technology leadership, with a focus on improving health outcomes and financial inclusion. She is a member of the Risk Committee.
|
| Ms Barbara Nelson | Non-Executive ChairmanNon-Executive Director | Oct 2023 |
Ms Nelson is a public board director and C-level technology leader, who currently serves on three corporate boards. She has been CEO twice and led global P&Ls as large as US$3 billion in companies ranging from Fortune 500 leaders to VC-funded companies. Barbara has scaled from concept to over US$100M - US$200M, four times in three companies, while delivering profitability. She brings board, P&L and general management experience in AI, SaaS/cloud services, IaaS, cybersecurity, biotech/healthcare, mobile, video, data management, storage, IT infrastructure, and semiconductors. He is a member of the Risk Committee.
|
| Mr Darragh Lyons | Chief Financial OfficerExecutive Director | Sep 2024 |
Mr Lyons was CEO of Malin plc, a listed life sciences investment company, where he previously served as CFO from 2015 until his appointment as CEO in 2019. Prior to that, Darragh held senior finance positions in Elan Pharmaceuticals plc and worked with PwC in Dublin, the U.S. and Canada.
|
| Ms Toni Pettit | Company Secretary | Sep 2024 |
-
|
| JP Howe | Chief Operating Officer |
-
|
|
| Niall O'Neill | Chief Product & Strategy Officer |
-
|
|
| Declan Bright | Chief Technology Officer |
-
|
|
| Toni Pettit | Company Secretary |
-
|
|
| Aaron Box | VP Strategy & Innovation |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 264,345,471 | 34.80% |
| Citicorp Nominees Pty Limited | 87,114,354 | 11.50% |
| Bell Potter Nominees Ltd <BB Nominees A/C> | 76,343,770 | 10.00% |
| HSBC Custody Nominees (Australia) Limited GSI EDA | 20,628,588 | 2.70% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 18,737,914 | 2.50% |
| UBS Nominees Pty Ltd | 15,990,006 | 2.10% |
| James Fitter | 14,933,090 | 2.00% |
| BNP Paribas Noms Pty Ltd | 14,785,849 | 1.80% |
| Longbridge Nominees Pty Limited <Longbridge A/C> | 13,697,318 | 1.80% |
| Manderrah Pty Limited | 12,236,435 | 1.60% |
| HSBC Custody Nominees (Australia) Limited i | 9,088,333 | 1.20% |
| BNP Paribas Noms Pty Ltd <Global Markets> | 7,652,368 | 1.00% |
| Top 4 Pty Ltd <The Foundation Inv S/F A/C> | 7,386,207 | 1.00% |
| Barana Capital Pty Limited <Shand Family A/C> | 6,802,956 | 0.90% |
| J P Morgan Nominees Australia Pty Limited | 5,828,363 | 0.80% |
| AJA Investments Pty Ltd <The Oliver Amelia Prop A/C> | 5,632,107 | 0.70% |
| Mark McCloskey | 5,479,868 | 0.70% |
| Berne No 132 Nominees Pty Ltd <W 1253672 A/C> | 5,161,111 | 0.70% |
| Walling Pty Ltd <CJ Howard Super Fund A/C> | 4,315,849 | 0.60% |
| OV No.1 Pty Ltd <The OV A/C> | 4,210,798 | 0.60% |
